SCHEMBL7200716

SCHEMBL7200716

OC(CCOc1ccc2ccccc2c1)N1CCC(O)(c2cnc3ccccc3c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LTA4H P09960 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HRH3 Q9Y5N1 5/20 0.36
ADA P00813 1/20 0.36
DRD3 P35462 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
PPARG P37231 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
OPRM1 P35372 2/20 0.35
OPRD1 P41143 2/20 0.35
OPRK1 P41145 2/20 0.35
OPRL1 P41146 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962978 0.93 PPARG (0.39) KDM4ELTA4HSMN1; SMN2PRMT5WDR77
SCHEMBL7969551 0.92 MEN1 (0.41) LTA4HSMN1; SMN2PRMT5WDR77KMT2A
SCHEMBL7953284 0.92 PDE10A (0.40) LTA4HDRD3PRMT5WDR77KMT2A
SCHEMBL7953343 0.91 ALDH1A1 (0.46) LTA4HSMN1; SMN2DRD3KMT2AMEN1
SCHEMBL7969474 0.91 MAPT (0.38) LTA4HSMN1; SMN2DRD3PRMT5WDR77
SCHEMBL7953566 0.91 OPRM1 (0.39) MAPK1LTA4HSMN1; SMN2KMT2AMEN1
SCHEMBL7969307 0.90 LTA4H (0.44) LTA4HSMN1; SMN2HRH3PRMT5WDR77
SCHEMBL7953451 0.90 LTA4H (0.38) LTA4HDRD3PRMT5WDR77KMT2A
SCHEMBL7965171 0.90 DRD2 (0.41) LTA4HDRD3KMT2AMEN1ALDH1A1
SCHEMBL7966948 0.90 OPRM1 (0.39) KDM4ELTA4HSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030004207-A1 USE OF COMPOUNDS WHICH ACTIVATE A 5-HT RECEPTOR TO TREAT URINARY INCONTINENCE SYNAPTIC PHARMACEUTICALS CORPORATION 2003-01-02 US disclosed
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed